BioLife Solutions, Inc. (NASDAQ: BLFS) develops, manufactures and markets patented hypothermic storage and cryopreservation solutions for cells and tissues. The company’s products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, delayed-onset cell damage, and death. BioLife’s HypoThermosol series of products includes: HypoThermosol FRS, a solution formulated to decrease the free radical accumulation in cells undergoing prolonged hypothermic preservation. For more information, visit the company’s website at www.biolifesolutions.com